Sjogren-Larsson Syndrome: Clinical Trials

1 trial for Sjogren-Larsson Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Sjogren-Larsson Syndrome: new trials by email Literature Review of Sjogren-Larsson Syndrome trials Research Report on Sjogren-Larsson Syndrome

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ADX-629 Therapy for Sjogren-Larsson Syndrome
ADX-629 - Sjogren-Larsson Syndrome
Phase 1 / Phase 2CompletedUniversity of Nebraska82023-01-022026-05-05

Narrower conditions

Cerebral Palsy (1)  ·  Ichthyosis (1)  ·  Intellectual Disability (1)  ·  Muscle Spasticity (1)  ·  Retinal Diseases (1)

Broader conditions

Brain Damage, Chronic (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Eye Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Infant, Newborn, Diseases (1)  ·  Keratosis (1)  ·  Lipid Metabolism Disorders (1)  ·  Lipid Metabolism, Inborn Errors (1)  ·  Lipidoses (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)

Interventions

ADX-629 (1)

Sponsors

University of Nebraska (1)

Countries

United States (1)

Top investigators

William B Rizzo, MD (1)